TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report
Abstract Background Thiamine-responsive megaloblastic anemia (TRMA) is a rare autosomal recessive inherited disease characterized by the clinical triad of megaloblastic anemia, sensorineural deafness, and diabetes mellitus. To date, only 100 cases of TRMA have been reported in the world. Case presen...
Main Authors: | Xin Li, Qing Cheng, Yu Ding, Qun Li, Ruen Yao, Jian Wang, Xiumin Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-07-01
|
Series: | BMC Pediatrics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12887-019-1608-2 |
Similar Items
-
Whole exome sequencing identifies a new mutation in the SLC19A2 gene leading to thiamine‐responsive megaloblastic anemia in an Egyptian family
by: Khalda Amr, et al.
Published: (2019-07-01) -
A Case of Resistant Megaloblastic Anemia Responding to Thiamine
by: A Bahrami- Ahmadi, et al.
Published: (2006-01-01) -
Case Report: Genetic and Clinical Features of Maternal Uniparental Isodisomy-Induced Thiamine-Responsive Megaloblastic Anemia Syndrome
by: Pengjiang Kang, et al.
Published: (2021-03-01) -
Dyserythropoiesis and myelodysplasia in thiamine‐responsive megaloblastic anemia syndrome
by: Mojgan Faraji‐Goodarzi, et al.
Published: (2020-06-01) -
Thiamine-responsive megaloblastic anemia syndrome: A case report
by: Omkar Patil, et al.
Published: (2020-01-01)